Apomorphine and dopamine D-1 receptor agonists increase the firing rates of subthalamic nucleus neurons

被引:107
作者
Kreiss, DS [1 ]
Anderson, LA [1 ]
Walters, JR [1 ]
机构
[1] NINCDS, EXPTL THERAPEUT BRANCH, NIH, BETHESDA, MD 20892 USA
基金
美国国家卫生研究院;
关键词
SKF; 38393; 82958; basal ganglia; electrophysiology; autoradiography;
D O I
10.1016/0306-4522(95)00583-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study investigated the regulation of spontaneous neuronal activity in the subthalamic nucleus by dopamine receptors using in vivo extracellular single unit recording techniques. Subthalamic nucleus neuronal firing rates were doubled by systemic administration of the nonselective dopamine receptor agonist apomorphine. The response to apomorphine was attenuated in animals anesthetized with chloral hydrate or ketamine. The dopamine D-2/D-3 receptor agonist quinpirole did not alter subthalamic nucleus neuronal firing rates. Firing rates were increased by the D-1 receptor agonists SKF 38393 and SKF 82958 two- to three-fold; these increases were reversed by the D-1 receptor antagonist, SCH 23390. Autoradiographic studies using [I-125]SCH 23982 indicated that D-1 family receptors were located along the ventral edge of the subthalamic nucleus and the dorsal aspect of the cerebral peduncle. Local administration of SKF 82958 into the subthalamic nucleus doubled neuronal firing rates; these increases were reversed by systemic administration of SCH 23390. Infusion of SCH 23390 into the subthalamic nucleus prevented systemic SKF 38393 from increasing the firing rates of subthalamic nucleus neurons. These results indicate that apomorphine and D-1 receptor agonists exert an excitatory influence on subthalamic nucleus neuronal activity. In addition, the excitation induced by D-1 receptor agonists appears to be mediated, at least in part, by D-1 receptors located in the vicinity of the subthalamic nucleus. The data suggest that basal ganglia output under conditions of increased dopamine receptor stimulation is influenced by the activation of excitatory subthalamic efferent pathways, as opposed to suppression of these pathways as predicted by current models of basal ganglia function.
引用
收藏
页码:863 / 876
页数:14
相关论文
共 95 条
[1]   CHANGES IN EXTRACELLULAR LEVELS OF GLUTAMATE AND ASPARTATE IN RAT SUBSTANTIA-NIGRA INDUCED BY DOPAMINE-RECEPTOR LIGANDS - IN-VIVO MICRODIALYSIS STUDIES [J].
ABARCA, J ;
GYSLING, K ;
ROTH, RH ;
BUSTOS, G .
NEUROCHEMICAL RESEARCH, 1995, 20 (02) :159-169
[2]   TOPOGRAPHICAL PROJECTIONS OF THE CEREBRAL-CORTEX TO THE SUBTHALAMIC NUCLEUS [J].
AFSHARPOUR, S .
JOURNAL OF COMPARATIVE NEUROLOGY, 1985, 236 (01) :14-28
[3]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[4]   DOPAMINE RECEPTOR AGONISTS - SELECTIVITY AND DOPAMINE-D1 RECEPTOR EFFICACY [J].
ANDERSEN, PH ;
JANSEN, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 188 (06) :335-347
[5]   LESION OF THE SUBTHALAMIC NUCLEUS FOR THE ALLEVIATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)-INDUCED PARKINSONISM IN THE PRIMATE [J].
AZIZ, TZ ;
PEGGS, D ;
SAMBROOK, MA ;
CROSSMAN, AR .
MOVEMENT DISORDERS, 1991, 6 (04) :288-292
[6]  
BENABID AL, 1994, STEREOT FUNCT NEUROS, V62, P76, DOI 10.1159/000098600
[7]   REVERSAL OF RIGIDITY AND IMPROVEMENT IN MOTOR-PERFORMANCE BY SUBTHALAMIC HIGH-FREQUENCY STIMULATION IN MPTP-TREATED MONKEYS [J].
BENAZZOUZ, A ;
GROSS, C ;
FEGER, J ;
BORAUD, T ;
BIOULAC, B .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1993, 5 (04) :382-389
[8]   THE PRIMATE SUBTHALAMIC NUCLEUS .2. NEURONAL-ACTIVITY IN THE MPTP MODEL OF PARKINSONISM [J].
BERGMAN, H ;
WICHMANN, T ;
KARMON, B ;
DELONG, MR .
JOURNAL OF NEUROPHYSIOLOGY, 1994, 72 (02) :507-520
[9]   REVERSAL OF EXPERIMENTAL PARKINSONISM BY LESIONS OF THE SUBTHALAMIC NUCLEUS [J].
BERGMAN, H ;
WICHMANN, T ;
DELONG, MR .
SCIENCE, 1990, 249 (4975) :1436-1438
[10]   DOPAMINE AGONISTS INCREASE PALLIDAL UNIT-ACTIVITY - ATTENUATION BY AGONIST PRETREATMENT AND ANESTHESIA [J].
BERGSTROM, DA ;
BROMLEY, SD ;
WALTERS, JR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 100 (01) :3-12